![[ Visit Client Website ]](images/banner.jpg)
Thursday, March 1, 2018
7:20 AM-3:15 PM
0001
32nd Annual Harold S. Nelson Military Allergy/Immunology Symposium TICKETED
Asthma
Session Details
Thursday, March 1, 2018: 7:20 AM-3:15 PM
Convention Center, South Concourse, Level 2, S220EF
6.50 CME/CE
Symposium
Moderator:
Taylor A. Banks, MD
Learning Objectives:
- Discuss emerging tryptase disorders and the process of evaluating affected patients
- Identify different asthma phenotypes/endotypes and targeted/personalized treatment approaches
- Discuss the limitations of a phenotype/endotypes-based approach to asthma management
Friday, March 2, 2018
4:00 PM-5:15 PM
1801
Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) Sister Society Symposium: Hot Topics in Allergy
Allergens/Allergy Testing/Allergy Therapeutics
Session Details
Friday, March 2, 2018: 4:00 PM-5:15 PM
Convention Center, South Concourse, Level 3, S330AB
1.25 CME/CE
Symposium
Primary Moderators:
Ignacio J. Ansotegui, MD PhD
Learning Objectives:
- Identify the clinical use of biomarkers (clinical, functional and molecular) to define candidate patients for different biologics and the relevance of interprofessional networking in severe asthma care
- Identify diagnosis and treatment of atopic dermatitis and angioedema
- Discuss the use of allergen molecular diagnosis to define and predict severe allergen reactions and properly define eligibility of patients to AIT
1802
Cannabis Exposure: An Emerging Allergen and Potential Workplace Hazard
Allergens/Allergy Testing/Allergy Therapeutics
Session Details
Friday, March 2, 2018: 4:00 PM-5:15 PM
Convention Center, South Concourse, Level 3, S310AB
1.25 CME/CE
Symposium
Primary Moderators:
David I. Bernstein, MD FAAAAI
William S. Silvers, MD FAAAAI
Learning Objectives:
- Discuss the hypersensitivity reactions and work-related contact urticaria to cannabis
- Describe the characterized Cannabis sativa allergens and the influence of cross-reactivity
- Discuss workplace microbial hazards associated with the cultivation, processing and handling of Cannabis sativa
1803
The Evolution of Practice Parameters: What You Need to Know to Interpret Guidelines in 2018
Allergy Office Practice
Session Details
Friday, March 2, 2018: 4:00 PM-5:15 PM
Convention Center, South Concourse, Level 2, S230EF
1.25 CME/CE
Symposium
Primary Moderators:
Jay M. Portnoy, MD FAAAAI
Alberto Martelli
Learning Objectives:
- Discuss the old and new guideline formats
- Discuss the GRADE format for guideline development
- Identify the practice parameters presented in the GRADE format
1804
17q21 Genes in Asthma: From Linkage to Function
Asthma
Session Details
Friday, March 2, 2018: 4:00 PM-5:15 PM
Convention Center, South Concourse, Level 2, S220EF
1.25 CME/CE
Symposium
Primary Moderators:
John W. Holloway, BSc PhD
Learning Objectives:
- Discuss the relationship between chromosome 17q21 genes and asthma
- Discuss the functions of ORMDL3 and GSDMB in airway remodeling in asthma
- Discuss the role of ORMDL3 in airway inflammation in asthma
1805
Biologics and Biomarkers for Asthma, Chronic Urticaria and Nasal Polyposis
Immune Mechanisms
Session Details
Friday, March 2, 2018: 4:00 PM-5:15 PM
Convention Center, South Concourse, Level 3, S320CD
1.25 CME/CE
Symposium
Primary Moderators:
Paula J. Busse, MD FAAAAI
Gilda Varricchi
Learning Objectives:
- Describe biomarkers to characterize the phenotype and endotype of asthma, chronic urticaria and nasal polyposis
- Discuss the results of key clinical trials using biologics for asthma, chronic urticaria and nasal polyposis
- Describe the role of biomarkers in choosing patients for biologic therapies
1806
Social and Ethnic Disparities Matter in Allergy
Food Allergy
Session Details
Friday, March 2, 2018: 4:00 PM-5:15 PM
Convention Center, South Concourse, Level 2, S220B
1.25 CME/CE
Symposium
Primary Moderators:
Gary Wing-Kin Wong, MD
Stanley M. Fineman, MD MBA FAAAAI
Learning Objectives:
- Describe the interplay between social and environmental factors in the development of allergic disorders
- Identify the risk factors and the protective factors for allergy associated with race and socioeconomic status
- Interpret the hygiene hypothesis in the context of inner city urban versus rural populations
1807
Immunotherapy: Future Perspectives
Allergens/Allergy Testing/Allergy Therapeutics
Session Details
Friday, March 2, 2018: 4:00 PM-5:15 PM
Convention Center, South Concourse, Level 3, S330GH
1.25 CME/CE
Symposium
Primary Moderators:
Mark S. Dykewicz, MD FAAAAI
Learning Objectives:
- Discuss the clinical benefits of SCIT and SLIT and how long they should be prescribed
- Discuss the use of modified allergens/adjuvant vaccines/peptide constructs for allergen immunotherapy
- Discuss the safety and the efficacy evidence of biologic and immunotherapy combination treatment
1808
The Epithelial Cell, Barrier Dysfuction and Immune Regulation in Allergic Inflammation
Immune Mechanisms
Session Details
Friday, March 2, 2018: 4:00 PM-5:15 PM
Convention Center, South Concourse, Level 3, S310GH
1.25 CME/CE
Symposium
Primary Moderators:
Caroline L. Sokol, MD PhD
Paul A. Greenberger, MD FAAAAI
Learning Objectives:
- Identify the novel mechanisms for how the epithelium activates and instructs the allergic immune response
1809
Opportunities to Answer Critical Questions about Asthma from NHLBI & NIAID
Asthma
Session Details
Friday, March 2, 2018: 4:00 PM-5:15 PM
Convention Center, South Concourse, Level 2, S230AB
1.25 CME/CE
Symposium
Moderator:
Christine A. Sorkness, PharmD
Learning Objectives:
- Describe approaches to phenotyping patients within a longitudinal cohort study
- Recognize and interpret biomarker variability over time in individuals with asthma
- Understand how analysis of biospecimens can augment clinical trial results
1810
AH Plenary: Multidisciplinary Care for Patients with Atopic Dermatitis
Allergic and Immunologic Skin Diseases
Session Details
Friday, March 2, 2018: 4:00 PM-5:15 PM
Hyatt, Convention Level, Plaza G
1.25 CME/CE
Symposium
Moderator:
Sally A. Noone, RN MSN
Learning Objectives:
- Describe barriers to effective disease control for patients with atopic dermatitis
- Describe the formation of a multidisciplinary team to care for children with atopic dermatitis
- Discuss the roles of multidisciplinary healthcare providers in the management of atopic dermatitis
Saturday, March 3, 2018
10:45 AM-12:00 PM
2301
Turkish National Society of Allergy and Clinical Immunology (TNSAI) Sister Society Symposium: Novel Perspectives of NSAID Exacerbated Respiratory Diseases
Drug/Insect Allergy/Vaccines
Session Details
Saturday, March 3, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S310AB
1.25 CME/CE
Symposium
Moderator:
Bulent Enis Sekerel, MD
Learning Objectives:
- Identify the spectrum of novel classifications of NSAID exacerbated respiratory diseases
- Describe the basic methods of aspirin desensitization in NERD as well as any new methods
- Identify a national model for standardizing follow-up for patients with NERD who underwent aspirin desensitization
2302
World Allergy Forum: New Approaches for the Optimal Management of Angioedema
Anaphylaxis/Urticaria/Angioedema
Session Details
Saturday, March 3, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S310GH
1.25 CME/CE
Symposium
Primary Moderators:
Ignacio J. Ansotegui, MD PhD
Mario Sanchez-Borges, MD FAAAAI
Learning Objectives:
- Discuss the current knowledge of the different mechanisms involved in the pathogenesis of angioedema
- Discuss the importance of the data from patient registries in understanding angioedema and efforts to address unmet needs, especially regarding hereditary angioedema
- Discuss the current and future symptomatic and prophylactic therapies for patients suffering different types of angioedema
2303
New Insights into T Lymphocyte Regulation
Immune Mechanisms
Session Details
Saturday, March 3, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S331A
1.25 CME/CE
Symposium
Primary Moderators:
Christina Nance, PhD MA FAAAAI
Learning Objectives:
- Identify the basic research related to T cell signaling and T cell memory responses
- Describe new knowledge on T cell signaling and function related to clinical scenarios
2304
Microbiome Manipulations for Allergic Disease
Immune Mechanisms
Session Details
Saturday, March 3, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 2, S220EF
1.25 CME/CE
Symposium
Moderator:
James E. Gern, MD FAAAAI
Learning Objectives:
- Discuss dysbiosis, the causal mechanisms of dysbiosis in allergic responses and the use of dysbiosis for diagnosis
- Explain the importance of germ-free mice and experimental systems to analyze dysbiosis
- Discuss the modification of microbiomes and prebiotics for the treatment of allergic diseases
2305
Indoor and Outdoor Air Pollution Create Health Disparities for Rural Asthma Patients
Asthma
Session Details
Saturday, March 3, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S330AB
1.25 CME/CE
Symposium
Primary Moderators:
Bruce G. Bender, PhD FAAAAI
R Maximiliano Gomez, MD PhD
Learning Objectives:
- Describe the role that environmental exposures play in disparities in health care outcomes for individuals with asthma living in different rural communities
- Identify underlying factors that may account for difficult-to-treat asthma in rural regions
- Describe efforts to mitigate severe asthma in rural patients
2306
NHLBI’s AsthmaNet Clinical Trial Results 2018
Asthma
Session Details
Saturday, March 3, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S330GH
1.25 CME/CE
Symposium
Primary Moderators:
William W. Busse, MD FAAAAI
James P. Kiley, PhD
Learning Objectives:
- Identify the preferred step-up therapy in African Americans ages 5 and older with asthma who are inadequately controlled on low dose ICS and the degree to which African ancestry affects preference for different therapies
- Discuss whether or not increasing from low to high dose ICS in the "yellow zone" reduces risk of severe asthma exacerbations
- Discuss the evidence linking the airway microbiome composition and the response to inhaled corticosteroids
2307
The Atopic March: What Have We Learned from the Natural History of Atopic Diseases
Immune Mechanisms
Session Details
Saturday, March 3, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 2, S230EF
1.25 CME/CE
Symposium
Primary Moderators:
Lanny J. Rosenwasser, MD FAAAAI
Alessandro Fiocchi, MD
Learning Objectives:
- Discuss epidemiological data that support the notion of the atopic March
- Discuss the genetic and molecular basis of the natural history of allergy
- Discuss strategies to prevent allergy development and progression
2308
Guidelines for the Evaluation and Management of Drug Hypersensitivity
Drug/Insect Allergy/Vaccines
Session Details
Saturday, March 3, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S320CD
1.25 CME/CE
Symposium
Primary Moderators:
Pascal M. Demoly, MD PhD
Edgardo J. Jares, MD
Learning Objectives:
- Discuss the expanded presentation of drug allergy and current phenotypes
- Identify guidelines for the best practices in the evaluation and management of reported drug allergy
- Discuss candidates for drug desensitization and the mechanisms of the multiple modalities
2310
AH: Evaluation and Management of the Pediatric Patient with Severe Asthma
Asthma
Session Details
Saturday, March 3, 2018: 10:45 AM-12:00 PM
Hyatt, Convention Level, Plaza H
1.25 CME/CE
Symposium
Moderator:
Caroline C. Horner, MD FAAAAI
Learning Objectives:
- Discuss the use of biologic therapies in pediatric patients with severe asthma
- Describe the appropriate assessment and management of the pediatric patient with severe asthma
- Outline potential barriers to care for the pediatric patient with severe asthma
2311
AH: Oral Food Challenges in Infants, FPIES and Alpha-Gal Allergy
Food Allergy
Session Details
Saturday, March 3, 2018: 10:45 AM-12:00 PM
Hyatt, Convention Level, Plaza G
1.25 CME/CE
Symposium
Moderator:
Jaime E. Ross, RN MSN
Learning Objectives:
- Discuss the process by which an oral food challenge is effectively conducted in the high-risk infant population
- Discuss the special considerations for conducting FPIES challenges including highlighting FPIES consensus guidelines
- Discuss the indication and interpretation of oral food challenges conducted in Alpha-Gal allergy patients
Sunday, March 4, 2018
10:45 AM-12:00 PM
3301
Latin American Society of Allergy, Asthma and Immunology (SLAAI) Sister Society Symposium: The Influence of Climate and Environmental Features Over Allergic Diseases
Allergens/Allergy Testing/Allergy Therapeutics
Session Details
Sunday, March 4, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S330AB
1.25 CME/CE
Symposium
Primary Moderators:
Edgardo J. Jares, MD
Patricia Latour-Staffeld, MD
Learning Objectives:
- Describe the potential harm of adverse environment and climate changes
- Identify the relationship between common allergic conditions like conjunctivitis and changes in the environment
- Discuss information on the latest findings of immunomodulation from parasites, under the scope of Latin America researchers
3302
EAACI: New Concepts in Managing Allergic Patients
Allergens/Allergy Testing/Allergy Therapeutics
Session Details
Sunday, March 4, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S330GH
1.25 CME/CE
Symposium
Moderator:
Peter W. Hellings, MD, PhD
Learning Objectives:
- Identify the key role of the allergen chambers in allergy and asthma
- Discuss the concept of environmental health and exposure science with the precision medicine approach in allergy and asthma
- Describe how to apply a new concept for evaluating severity of allergic reactions
3303
Cost-Effectiveness of Pharmaceutical and Environmental Interventions for Asthma
Asthma
Session Details
Sunday, March 4, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 2, S230EF
1.25 CME/CE
Symposium
Primary Moderators:
Carlos A. Ferreira Nunes, MD
Christopher D. Codispoti, MD PhD FAAAAI
Learning Objectives:
- Describe the methodology and application of cost-effectiveness analysis in asthma
- Identify cost-effective pharmaceutical asthma strategies from the currently available options
- Identify cost-effective environmental interventions for asthma
3304
Human Immune System Variation in Health and Disease
Immune Mechanisms
Session Details
Sunday, March 4, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 2, S230AB
1.25 CME/CE
Symposium
Primary Moderators:
David D. Chaplin, MD PhD FAAAAI
José Antonio Ortega Martell, MD
Learning Objectives:
- Discuss the various studies using cutting-edge and high throughput technologies to determine the normal and temporal variations of human immune responses
- Describe recent studies unraveling the environmental impact on human immune responses
- Describe recent findings in allergen-specific immune responses in normal and allergic individuals
3305
New Developments in Atopic Dermatitis and Implications for the Atopic March
Allergic and Immunologic Skin Diseases
Session Details
Sunday, March 4, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S320CD
1.25 CME/CE
Symposium
Moderator:
Lynda C. Schneider, MD FAAAAI
Learning Objectives:
- Discuss the basis of emerging anti-cytokine(anti-TH2, Th22 and Th 17) biologics in the treatment of AD
- Discuss other potential therapeutic targets for AD, including JAK inhibitors, PDE4 antagonists, H4R antagonists in AD, and which inflammatory axes are targeted in clinical efficacy and safety data
- Discuss new strategies for preventing AD in hgh risk children and their potential role in preventing other atopic manifestations such as food allergies
3306
Optimal Allergens for Diagnostic Testing and Immunotherapy: Are We Using the Best Allergens and How Can They Be Improved?
Allergens/Allergy Testing/Allergy Therapeutics
Session Details
Sunday, March 4, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S310GH
1.25 CME/CE
Symposium
Primary Moderators:
Fernan M. Caballero Fonseca, MD
David I. Bernstein, MD FAAAAI
Learning Objectives:
- Describe how allergens are identified, measured and prepared for testing and treatment
- Discuss American and European processes for measuring and obtaining allergens for testing and treatment
- Identify new forms of allergen immunotherapy and how immunotherapy will be administered in the future
3307
Chitinases: Accomplices in Chronic Allergic Inflammation or Friends in Wound Repair?
Immune Mechanisms
Session Details
Sunday, March 4, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 2, S220EF
1.25 CME/CE
Symposium
Primary Moderators:
Ajay P Nayak, PhD
Juan Carlos Sisul, MD
Learning Objectives:
- Identify chitinases in the contexts of disease severity, tissue injury and homeostasis
- Identify environmental sources of chitin and establish an immunological role for chitinases in eosinophil recruitment
- Discuss the clinical relevance of chitinase enzymes in asthma and COPD with emphasis on disease exacerbations and therapy
3308
The Epithelium as Boss: Lessons from the AADCRC
Immune Mechanisms
Session Details
Sunday, March 4, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S310AB
1.25 CME/CE
Symposium
Primary Moderators:
Mubeccel Akdis, MD PhD
Alkis Togias, MD FAAAAI
Learning Objectives:
- Describe the mechanisms by which the major airway mucins MUC5AC and MUC5B are organized within the mucus gel and how this gel contributes to airway obstruction in asthma
- Describe the endogenous pathway that normally curtails the development of Th2 immunity at the squamous mucosa mediated by the serine protease inhibitor SPINK7, whose loss of function is involved in unleashing marked Th2 related responses
- Describe the role of surfactant protein A in regulating allergic airway disease
3310
AH: Food Allergy Management: Challenges in Working with Special Populations
Food Allergy
Session Details
Sunday, March 4, 2018: 10:45 AM-12:00 PM
Hyatt, Convention Level, Regency V
1.25 CME/CE
Symposium
Moderator:
Sally A. Noone, RN MSN
Learning Objectives:
- Identify obstacles as well as ideas to successfully work with special populations in the management of food allergy
3311
AH: Management of Feeding Difficulties in Non-IgE Mediated Food Allergy
Food Allergy
Session Details
Sunday, March 4, 2018: 10:45 AM-12:00 PM
Hyatt, Convention Level, Regency 0
1.25 CME/CE
Symposium
Moderator:
Ruchi S. Gupta, MD MPH
Learning Objectives:
- Identify the difference between typical childhood eating patterns and feeding complications as a result of EoE
- Identify how FPIES reactions may lead to feeding difficulties
- Identify strategies to help pediatric patients and their families overcome food phobias
Monday, March 5, 2018
10:45 AM-12:00 PM
4301
Japanese Society of Allergology (JSA) Sister Society Symposium: Barrier Dysfunction in Allergic Diseases
Immune Mechanisms
Session Details
Monday, March 5, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 2, S220EF
1.25 CME/CE
Symposium
Primary Moderators:
Hirohisa Saito, MD PhD FAAAAI
Motohiro Ebisawa, MD PhD FAAAAI
Learning Objectives:
- Discuss the barrier function at the mucosal surfaces
4302
Allergies, Asthma and Environmental Risk Factors in a Changing World
Asthma
Session Details
Monday, March 5, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 2, S230EF
1.25 CME/CE
Symposium
Primary Moderators:
Jay M. Portnoy, MD FAAAAI
Sandra Nora González- Diaz, MD PhD FAAAAI FACAAI, EAACI
Learning Objectives:
- Describe the impact of environmental factors on the development of allergies and asthma in migrants
- Describe the impact of pesticides and pollutants on childhood asthma
- Describe the impact of air pollution on biodiversity and allergic diseases, especially airway allergies in the developing world
4303
The Effects of a Warming Climate on the Diagnosis and Treatment of Asthma
Asthma
Session Details
Monday, March 5, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S310GH
1.25 CME/CE
Symposium
Primary Moderators:
Elham M. Hossny, MD PhD FAAAAI
Menachem Rottem, MD FAAAAI
Learning Objectives:
- Discuss global warming as it impacts CO2, nitrous oxide, greenhouse gases and biomasses
- Discuss the changing pollination patterns and duration of seasons from global warming
- Describe how the meteorological changes can precipitate acute, serious exacerbations of asthma and diagnostic considerations of such events
4304
Update in PIDD Diagnostics and Treatments
Immunodeficiency
Session Details
Monday, March 5, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S330AB
1.25 CME/CE
Symposium
Primary Moderators:
Kathleen E. Sullivan, MD PhD FAAAAI
Ricardo U. Sorensen, MD
Learning Objectives:
- Identify common diagnostic algorithms for evaluating PIDDs
- Explain caveats of genetic testing
- Identify appropriate treatment options for PIDDs
4305
Advances in Aeroallergen Immunotherapy
Allergens/Allergy Testing/Allergy Therapeutics
Session Details
Monday, March 5, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S330GH
1.25 CME/CE
Symposium
Moderator:
Desiree E.S. Larenas Linnemann, MD FAAAAI
Learning Objectives:
- Discuss how SCIT and SLIT are currently used in Europe
- Discuss the roles of SLIT and SCIT in the United States, including the preference for multiallergen SCIT
- Describe the use of polymerized extracts
4306
Shaping Type 2 Inflammation: The Role of ILC2
Immune Mechanisms
Session Details
Monday, March 5, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 2, S220B
1.25 CME/CE
Symposium
Primary Moderators:
Taylor Alan Doherty, MD FAAAAI
Learning Objectives:
- Discuss the importance of ILC2 cells in maintaining homeostasis and mediating allergic airway inflammation through controlled mechanisms
4307
From the Exam Room to the Neighborhood: Targeting the Indoor Environment as a Public Health Strategy for Asthma
Allergens/Allergy Testing/Allergy Therapeutics
Session Details
Monday, March 5, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 2, S230AB
1.25 CME/CE
Symposium
Primary Moderators:
Elizabeth Matsui, MD MHS
Noel Rodriguez Perez, MD FAAAAI
Learning Objectives:
- Describe the controversies and future directions of indoor environmental interventions as a component of a public health and population health approach to asthma management
- Discuss the rationale for, and approaches to, dissemination of research findings from community-engaged research
4308
Early Life Environmental Exposures Regulate Host Allergic Immune Responses: Lessons Learned from the AADCRC Birth Cohorts
Asthma
Session Details
Monday, March 5, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S310AB
1.25 CME/CE
Symposium
Moderator:
Wendy F. Davidson, PhD
Learning Objectives:
- Discuss and reveal the unpublished data from University of Wisconsin WISC cohort that defines the early life environmental exposures that significantly decreased respiratory infections during the first 2 years of life in farm children compared to non-farm children
- Discuss the strains of the ubiquitous respiratory syncytial virus (RSV) that are associated with increased risk of severe infant illness and later wheezing, which we call RSV strains, as proposed by the Vanderbilt University INSPIRE cohort
- Describe the epidemiology between traffic-related air pollution and childhood asthma as defined by the Cincinnati Children's Hospital CCAAPS birth cohort